123 related articles for article (PubMed ID: 11845260)
1. The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation.
Huang A; Quinn H; Glover C; Henderson DC; Allen-Mersh TG
Cancer Immunol Immunother; 2002 Mar; 51(1):53-7. PubMed ID: 11845260
[TBL] [Abstract][Full Text] [Related]
2. Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer.
Huang A; Fuchs D; Widner B; Glover C; Henderson DC; Allen-Mersh TG
Br J Cancer; 2002 Jun; 86(11):1691-6. PubMed ID: 12087451
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
[TBL] [Abstract][Full Text] [Related]
4. Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer.
Shibata M; Takekawa M; Amano S
Surg Today; 1998; 28(9):884-8. PubMed ID: 9744395
[TBL] [Abstract][Full Text] [Related]
5. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.
Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595
[TBL] [Abstract][Full Text] [Related]
6. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.
Rea IM; McNerlan SE; Alexander HD
Exp Gerontol; 1999 Jan; 34(1):79-93. PubMed ID: 10197730
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis.
Ueda T; Shimada E; Urakawa T
J Gastroenterol; 1994 Aug; 29(4):423-9. PubMed ID: 7951851
[TBL] [Abstract][Full Text] [Related]
8. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori.
Karttunen R
Clin Exp Immunol; 1991 Mar; 83(3):396-400. PubMed ID: 1900743
[TBL] [Abstract][Full Text] [Related]
9. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
10. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
11. Quantitative flow cytometry shows activation of the TNF-alpha system but not of the IL-2 system at the single cell level in renal replacement therapy.
van Riemsdijk-Van Overbeeke IC; Baan CC; Knoop CJ; Loonen EH; Zietse R; Weimar W
Nephrol Dial Transplant; 2001 Jul; 16(7):1430-5. PubMed ID: 11427636
[TBL] [Abstract][Full Text] [Related]
12. High serum carcinoembryonic antigen concentration in patients with colorectal liver metastases is associated with poor cell-mediated immunity, which is predictive of survival.
King J; Caplehorn JR; Ross WB; Morris DL
Br J Surg; 1997 Oct; 84(10):1382-5. PubMed ID: 9361594
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the cytokine and acute-phase response to major surgery by recombinant interleukin-2.
Deehan DJ; Heys SD; Simpson W; Broom J; McMillan DN; Eremin O
Br J Surg; 1995 Jan; 82(1):86-90. PubMed ID: 7881967
[TBL] [Abstract][Full Text] [Related]
14. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
Barber MD; Fearon KC; Ross JA
Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-Lymphocyte Ratio and Intratumoral CD45RO-Positive T Cells as Predictive Factors for Longer Survival of Patients with Colorectal Liver Metastasis after Hepatectomy.
Hamada T; Ishizaki H; Haruyama Y; Hamada R; Yano K; Kondo K; Kataoka H; Nanashima A
Tohoku J Exp Med; 2020 Aug; 251(4):303-311. PubMed ID: 32779620
[TBL] [Abstract][Full Text] [Related]
16. HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients.
Janssen RA; Buter J; Straatsma E; Heijn AA; Sleijfer DT; de Vries EG; Mulder NH; The TH; de Leij L
Cancer Immunol Immunother; 1993; 36(3):198-204. PubMed ID: 8439981
[TBL] [Abstract][Full Text] [Related]
17. Activation of HLA-DR and interleukin-6 gene transcription in resting T cells via the CD2 molecule: relevance to chronic immune-mediated inflammation.
Linardopoulos S; Corrigall V; Panayi GS
Scand J Immunol; 1992 Sep; 36(3):469-77. PubMed ID: 1355612
[TBL] [Abstract][Full Text] [Related]
18. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
19. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.
Davas EM; Tsirogianni A; Kappou I; Karamitsos D; Economidou I; Dantis PC
Clin Rheumatol; 1999; 18(1):17-22. PubMed ID: 10088943
[TBL] [Abstract][Full Text] [Related]
20. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
